Other content tagged: Surfactant
Respiratory distress syndrome (RDS) in preterm babies
Interview with Associate Professor Luke Jardine Luke Jardine works as Staff Specialist Neonatology at Mater Hospital, Brisbane, Australia, Division of Neonatology. He is the author of numerous research publications in the field of neonatology with a focus on preterm birth and neonatal intensive care. Professor Jardine, respiratory distress syndrome (RDS) is a quite serious complication mainly in preterm babies, can you give us a little more background on the disease and explain which babies are primarily at risk? RDS…
Read more
Surfactant replacement therapy – a milestone in neonatology
The Respiratory Distress Syndrome (RDS) is a lung disorder that is mostly seen in preterm babies, especially those born before week 30. It is caused by a lack of surfactant, which is a substance that coats the inside of the lungs and prevents the small air sacs (alveoli) from collapsing.1 In preparation for breathing air, fetuses begin producing surfactant during the third trimester of pregnancy through labour and delivery. Depending on the level of prematurity, the lungs of a baby…
Read more
The benefits of the less invasive surfactant application (LISA) in preterm infants
Infants born without enough surfactant may develop a condition called respiratory distress syndrome (RDS). RDS occurs in preterm infants due to the immaturity of their lungs and inability to make sufficient surfactant. On the occasion of our topic of the month “Patient safety and hygiene practice”, we spoke with the neonatologist Dr Angela Kribs, Germany, who together with further experts investigated a less invasive surfactant application protocol (LISA) in extremely preterm infants. The Nonintubated Surfactant Application trial was a multicenter,…
Read more
